Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells
Baylor College of Medicine researchers extend the life and effectiveness of off-the-shelf, cancer-fighting immune T cells.
Read moreBaylor College of Medicine researchers extend the life and effectiveness of off-the-shelf, cancer-fighting immune T cells.
Read moreCAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read moreClinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read moreFrom the Labs celebrates Women’s History Month with a series of posts highlighting the work of Baylor Women of Science. Here is the first post
Read moreT cell therapies have demonstrated encouraging results and benefits in patients with lymphoma resistant to chemotherapy, but, despite these advances, a large number of patients
Read moreA bone marrow transplant can be a life-saving treatment for patients with certain cancers and other serious illnesses that have not responded to conventional chemotherapies.
Read moreTreating cancer with the patient’s own immune cells has been successful. In particular, treating B cell malignancies with the patients’ own immune T cells modified
Read more